May 2nd – Food and Drug Administration , otherwise known as FDA proposed that the antidepressant manufacturers shall include a warning of increased risk of suicidal thinking and behavior in young adults aged 18 to 24 during initial treatment on the existing black box of their products labeling.
FDA proposal is based on their internal committee’s finding on 77,000 adult patients with major depressive disorders.
If you are currently taking an antidepressant, FDA advises that you should consult with your doctor to discuss the best course of action if there are signs of worsening [tag-tec]depression[/tag-tec], or the emergence of suicidal thinking. Never stop taking the antidepressant without your doctor’s permission.
In reality, FDA recognizes this fact in 2005 but did not prohibit children and adolescents from receiving antidepressants to treat depression and other psychiatric disorders under recent scientific findings. In addition, the sales of antidepressants have decrease tremendously when the black box waning was put on the drug labeling to alert doctors and patients of the suicide risk. I guess commercial element play a small part here too.
Via Foodconsumer.org
If you would like to make a comment, please fill out the form below.
